1. Home
  2. XBIT vs CATO Comparison

XBIT vs CATO Comparison

Compare XBIT & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.28

Market Cap

69.8M

Sector

Health Care

ML Signal

HOLD

Logo Cato Corporation (The)

CATO

Cato Corporation (The)

HOLD

Current Price

$3.34

Market Cap

58.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIT
CATO
Founded
2005
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
69.8M
58.0M
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
XBIT
CATO
Price
$2.28
$3.34
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
35.4K
117.1K
Earning Date
05-08-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
68.04
EPS
N/A
0.47
Revenue
N/A
$653,812,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$7.02
Revenue Growth
N/A
0.62
52 Week Low
$2.09
$2.59
52 Week High
$3.61
$4.92

Technical Indicators

Market Signals
Indicator
XBIT
CATO
Relative Strength Index (RSI) 49.46 49.59
Support Level $2.27 $2.81
Resistance Level $2.32 $3.52
Average True Range (ATR) 0.05 0.15
MACD 0.00 0.00
Stochastic Oscillator 72.00 45.24

Price Performance

Historical Comparison
XBIT
CATO

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About CATO Cato Corporation (The)

The Cato Corp seeks to offer quality fashion apparel and accessories at low prices every day, in junior/missy and plus sizes. The Cato concept's stores and e-commerce website feature a broad assortment of apparel and accessories, including dressy, career, and casual sportswear, dresses, coats, shoes, lingerie, costume jewelry, and handbags. Management believes the Company's success is dependent upon its ability to differentiate its stores from department stores, mass merchandise discount stores, and competing specialty stores. The key elements of the Company's business are: Merchandise Assortment, Value Pricing, Strip Shopping Center Location, Customer Service, Credit and Layaway Programs.

Share on Social Networks: